PCI Biotech Holding ASA Company Description
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform.
The company’s technology platform consists of a proprietary small molecule photosensitiser (fimaporfin) and a light source; and develops photochemical internalisation (PCI), inducing light-triggered intracellular release for various therapeutic modalities, as well as photochemical lysis (PCL) comprising light-triggered cell lysis, which enhances yield and purity in viral vector manufacturing.
It also explores for intratumoural immunotherapy therapeutics that identifies novel treatment combinations to overcome resistance to immune-checkpoint inhibitors and safety-issues associated with treatments; and develops nucleic acid therapeutics to improve the treatment of dermatological diseases.
In addition, the company develops fimaVACC for immunotherapy indications, which is in pre-clinical study; fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study for bioprocessing and dermatology indications; and technology for viral vector manufacturing and pre-clinical research for intratumoural immunotherapy.
PCI Biotech Holding ASA was incorporated in 2007 and is headquartered in Oslo, Norway.
![PCI Biotech Holding ASA logo](https://img.stockanalysis.com/logos1/OL/PCIB.png)
Country | Norway |
Founded | 2007 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 6 |
CEO | Ronny Skuggedal |
Contact Details
Address: UllernchaussEen 64 Oslo, 0379 Norway | |
Phone | 47 67 11 54 00 |
Website | pcibiotech.com |
Stock Details
Ticker Symbol | PCIB |
Exchange | Oslo Børs |
Fiscal Year | January - December |
Reporting Currency | NOK |
ISIN Number | NO0010405640 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Ronny Skuggedal | Chief Executive Officer and Chief Financial Officer |
Dr. Anders Hogset Ph.D. | Chief Scientific Officer |